In summary, we conclude that CAV2 is an oncogenic gene in pancreatic cancer that exerts its oncogenic effect by targeting Wnt7A to activate the Wnt/β-catenin signalling pathway activity. Here, WNT7A is linked to pancreatic neoplasm.